BDX
Price
$224.90
Change
-$2.55 (-1.12%)
Updated
Mar 11, 04:59 PM (EDT)
Capitalization
71.49B
50 days until earnings call
QDEL
Price
$37.29
Change
-$1.39 (-3.59%)
Updated
Mar 11, 04:59 PM (EDT)
Capitalization
3.14B
49 days until earnings call
Ad is loading...

BDX vs QDEL

Header iconBDX vs QDEL Comparison
Open Charts BDX vs QDELBanner chart's image
Becton Dickinson and
Price$224.90
Change-$2.55 (-1.12%)
Volume$9.08K
Capitalization71.49B
QuidelOrtho
Price$37.29
Change-$1.39 (-3.59%)
Volume$100.4K
Capitalization3.14B
BDX vs QDEL Comparison Chart
Loading...
BDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QDEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BDX vs. QDEL commentary
Mar 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BDX is a Hold and QDEL is a Hold.

Ad is loading...
COMPARISON
Comparison
Mar 12, 2025
Stock price -- (BDX: $227.45 vs. QDEL: $38.69)
Brand notoriety: BDX and QDEL are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BDX: 121% vs. QDEL: 93%
Market capitalization -- BDX: $71.49B vs. QDEL: $3.14B
BDX [@Medical Specialties] is valued at $71.49B. QDEL’s [@Medical Specialties] market capitalization is $3.14B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BDX’s FA Score shows that 1 FA rating(s) are green whileQDEL’s FA Score has 1 green FA rating(s).

  • BDX’s FA Score: 1 green, 4 red.
  • QDEL’s FA Score: 1 green, 4 red.
According to our system of comparison, both BDX and QDEL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BDX’s TA Score shows that 5 TA indicator(s) are bullish while QDEL’s TA Score has 3 bullish TA indicator(s).

  • BDX’s TA Score: 5 bullish, 6 bearish.
  • QDEL’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, BDX is a better buy in the short-term than QDEL.

Price Growth

BDX (@Medical Specialties) experienced а +0.02% price change this week, while QDEL (@Medical Specialties) price change was -0.92% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.36%. For the same industry, the average monthly price growth was -7.35%, and the average quarterly price growth was -3.83%.

Reported Earning Dates

BDX is expected to report earnings on May 01, 2025.

QDEL is expected to report earnings on Apr 30, 2025.

Industries' Descriptions

@Medical Specialties (-1.36% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BDX($71.5B) has a higher market cap than QDEL($3.14B). BDX has higher P/E ratio than QDEL: BDX (55.97) vs QDEL (9.76). BDX YTD gains are higher at: 0.712 vs. QDEL (-13.154). BDX has higher annual earnings (EBITDA): 4.28B vs. QDEL (607M). BDX has more cash in the bank: 1.18B vs. QDEL (167M). QDEL has less debt than BDX: QDEL (2.61B) vs BDX (16.1B). BDX has higher revenues than QDEL: BDX (19.5B) vs QDEL (3B).
BDXQDELBDX / QDEL
Capitalization71.5B3.14B2,276%
EBITDA4.28B607M706%
Gain YTD0.712-13.154-5%
P/E Ratio55.979.76574%
Revenue19.5B3B650%
Total Cash1.18B167M708%
Total Debt16.1B2.61B616%
FUNDAMENTALS RATINGS
BDX vs QDEL: Fundamental Ratings
BDX
QDEL
OUTLOOK RATING
1..100
6170
VALUATION
overvalued / fair valued / undervalued
1..100
10
Undervalued
57
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
7694
PRICE GROWTH RATING
1..100
5298
P/E GROWTH RATING
1..100
8412
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BDX's Valuation (10) in the Medical Specialties industry is somewhat better than the same rating for QDEL (57). This means that BDX’s stock grew somewhat faster than QDEL’s over the last 12 months.

BDX's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as QDEL (100). This means that BDX’s stock grew similarly to QDEL’s over the last 12 months.

BDX's SMR Rating (76) in the Medical Specialties industry is in the same range as QDEL (94). This means that BDX’s stock grew similarly to QDEL’s over the last 12 months.

BDX's Price Growth Rating (52) in the Medical Specialties industry is somewhat better than the same rating for QDEL (98). This means that BDX’s stock grew somewhat faster than QDEL’s over the last 12 months.

QDEL's P/E Growth Rating (12) in the Medical Specialties industry is significantly better than the same rating for BDX (84). This means that QDEL’s stock grew significantly faster than BDX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BDXQDEL
RSI
ODDS (%)
Bearish Trend 5 days ago
64%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
44%
Bullish Trend 2 days ago
69%
Momentum
ODDS (%)
Bearish Trend 2 days ago
48%
Bearish Trend 2 days ago
76%
MACD
ODDS (%)
Bullish Trend 2 days ago
51%
Bearish Trend 2 days ago
70%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
47%
Bearish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
38%
Bearish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 5 days ago
47%
Bullish Trend 5 days ago
70%
Declines
ODDS (%)
Bearish Trend 7 days ago
41%
Bearish Trend 8 days ago
79%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
56%
Bullish Trend 2 days ago
70%
Aroon
ODDS (%)
Bearish Trend 2 days ago
29%
Bearish Trend 2 days ago
76%
View a ticker or compare two or three
Ad is loading...
BDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QDEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HIOCX16.94N/A
N/A
Hartford International Opportunities C
HMVCX10.31N/A
N/A
Hartford MidCap Value C
BRWAX23.41N/A
N/A
MFS Blended Research Growth Eq A
IENRX9.31N/A
N/A
Macquarie Climate Solutions R6
AIVSX56.22-1.44
-2.50%
American Funds Invmt Co of Amer A

BDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BDX has been loosely correlated with HOLX. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if BDX jumps, then HOLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BDX
1D Price
Change %
BDX100%
-0.46%
HOLX - BDX
52%
Loosely correlated
+1.69%
STE - BDX
45%
Loosely correlated
-0.52%
ZBH - BDX
40%
Loosely correlated
+2.46%
MDT - BDX
39%
Loosely correlated
-0.74%
ABT - BDX
39%
Loosely correlated
+0.16%
More

QDEL and

Correlation & Price change

A.I.dvisor indicates that over the last year, QDEL has been loosely correlated with BIO. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if QDEL jumps, then BIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QDEL
1D Price
Change %
QDEL100%
-5.17%
BIO - QDEL
46%
Loosely correlated
-5.14%
DHR - QDEL
42%
Loosely correlated
-3.23%
IQV - QDEL
41%
Loosely correlated
-1.49%
CRL - QDEL
40%
Loosely correlated
-0.45%
BDX - QDEL
37%
Loosely correlated
-0.46%
More